Pharmacogenetics of lithium response in bipolar disorder

Author： McCarthy Michael J   Leckband Susan G   Kelsoe John R  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.10, 2010-10, pp. : 1439-1465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics of Bipolar Disorder

By  

Current Pharmacogenomics, Vol. 1, Iss. 4, 2003-12 ,pp. : 269-276

Bentham Science Publishers

Access to resources Recommend Favorite

Lithium: agent of choice in bipolar disorder

By  

Inpharma, Vol. 1, Iss. 1336, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Lithium Erythrocyte Concentration and Neurological Toxicity in Bipolar Disorder

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 2, 2005-06 ,pp. : 103-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neuroprotective Effects of Lithium in Patients with Bipolar Disorder

By  

Current Psychopharmacology, Vol. 4, Iss. 2, 2016-02 ,pp. : 96-102

Bentham Science Publishers

Access to resources Recommend Favorite

Is Lithium Still the Maintenance Treatment of Choice for Bipolar Disorder?

By Silverstone T.  

CNS Drugs, Vol. 14, Iss. 2, 2000-08 ,pp. : 81-94

Adis International

Access to resources Recommend Favorite